Medico Remedies Ltd. (MEDICO) Share Price Surges 8.73% Today

Medico Remedies Ltd. Share Price surged 8.73% today, reaching Rs 44.2 with a market cap of Rs 337.33 crore.

Medico Remedies Ltd. Share Price experienced a notable surge today, rising by 8.73% to reach Rs 44.2. This significant price movement places the company in the spotlight within the micro-cap category, where it exceeded the qualifying threshold of 8.1%. With a market capitalisation of Rs 337.33 crore, Medico Remedies Ltd. has captured investor attention, making it one of today's top gainers. The stock's performance today is noteworthy, as it reflects a strong market interest despite the absence of a specific company-related catalyst in the supplied data.

Today's price rise for Medico Remedies Ltd. highlights the dynamic nature of the stock market, where investor sentiment and market conditions can drive significant movements. As the company operates within the Pharmaceuticals & Drugs industry, its performance is closely watched by investors seeking opportunities in the healthcare sector. Univest continues to monitor such developments to provide comprehensive insights into stock movements and market trends.

Medico Remedies Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 44.2
Previous Close	Rs 40.65
Today's Change	+Rs 3.55 (+8.73%)
Day Open	Rs 42.22
Day High	Rs 44.31
Day Low	Rs 40.2
Current Volume (BSE)	17,405
BSE Traded Volume	17,405
NSE Traded Volume	9,02,320
Combined NSE + BSE Volume	9,19,725
Turnover	Rs 0.08 crore
Market Capitalisation	Rs 337.33 crore
Market Cap Category	Micro Cap
Qualifying Threshold Cleared	8.1%

Medico Remedies Ltd. opened at Rs 42.22 today, reaching a high of Rs 44.31 and a low of Rs 40.2 before closing at Rs 44.2. The stock's previous close was Rs 40.65, resulting in a day change of Rs 3.55. The total volume traded today was 919,725 shares, with a turnover of Rs 0.08 crore, indicating robust trading activity. The volume ratio suggests heightened participation compared to the average, reflecting increased investor interest.

As a micro-cap stock, Medico Remedies Ltd. had to clear a qualifying threshold of 8.1% to be considered a top gainer today. The stock's 8.73% rise comfortably surpassed this threshold, underscoring its strong performance in the market. This price action analysis provides a detailed view of the stock's movement, offering insights into its trading dynamics and investor engagement.

Medico Remedies Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 337.33 crore
P/E Ratio	25.72x
P/B Ratio	4.47x
ROE	8.31%
ROCE	10.13%
EPS	Rs 1.58
Book Value Per Share	Rs 9.1
Dividend Yield	0%

Medico Remedies Ltd. was valued at a P/E ratio of 25.72x, a P/B ratio of 4.47x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 8.31% and ROCE of 10.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 1.58, book value per share of Rs 9.1, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Medico Remedies Ltd. operates with a market capitalisation of Rs 337.33 crore and an enterprise value that reflects its financial standing. The company's P/E ratio of 25.72 is above the industry median of 18.4, suggesting a relatively higher valuation compared to its peers. The P/B ratio stands at 4.47, significantly above the industry median of 1.84, indicating a premium valuation in terms of book value.

The company's return on equity (ROE) is 8.31%, slightly below the industry median of 9.93%, while the return on capital employed (ROCE) is 10.13%, also below the industry median of 12.97%. These metrics suggest that while the company is profitable, its returns are slightly lower than the industry average. The earnings per share (EPS) of Rs 1.58 and a book value of Rs 9.1 per share provide additional context to its financial health.

Medico Remedies Ltd. does not currently offer a dividend yield, which may influence investor decisions regarding income generation from this stock. Overall, the fundamental analysis highlights the company's valuation metrics and profitability, offering insights into its financial performance within the healthcare sector.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Companies in Benchmark	137
Company P/E Ratio	25.72x
Benchmark Median P/E	18.4x
Benchmark Average P/E	58.53x
Benchmark P/E Range	0x to 3,482.29x
Companies with P/E Data	137
Company P/B Ratio	4.47x
Benchmark Median P/B	1.84x
Company ROE	8.31%
Benchmark Median ROE	9.93%
Company ROCE	10.13%
Benchmark Median ROCE	12.97%
Company Market Capitalisation	Rs 337.33 crore
Benchmark Median Market Cap	Rs 151.12 crore

Medico Remedies Ltd. (MEDICO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs. The numerical benchmark uses 137 same industry companies from the supplied master-data set.

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 25.72x, which is above the benchmark median of 18.4x, a difference of +39.78%. The benchmark contains 137 companies with P/E data, ranging from 0x to 3,482.29x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Medico Remedies Ltd. (MEDICO) has a ROE of 8.31%, which is below the benchmark median of 9.93%, a difference of -16.31%. Medico Remedies Ltd. (MEDICO) has a ROCE of 10.13%, which is below the benchmark median of 12.97%, a difference of -21.9%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Medico Remedies Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry. The sector snapshot reveals that the company is part of a competitive landscape with 137 companies in the same industry. The industry benchmark P/E median is 18.4, with a range extending from 0 to 3482.29. Medico Remedies Ltd.'s P/E ratio of 25.72 places it above the median, indicating a higher valuation relative to many peers.

The company's P/B ratio of 4.47 is significantly above the industry median of 1.84, suggesting a premium valuation. However, its ROE of 8.31% and ROCE of 10.13% are below the industry medians of 9.93% and 12.97%, respectively, indicating room for improvement in profitability metrics. The market capitalisation of Rs 337.33 crore is above the industry median of Rs 151.12 crore, positioning Medico Remedies Ltd. as a notable player within its sector.

The Healthcare sector, with its focus on pharmaceuticals and drugs, remains a critical area for investors seeking growth opportunities. Medico Remedies Ltd.'s position within this sector, combined with its valuation metrics, provides a comprehensive view of its market standing and potential for future growth.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
BDH Industries Ltd.	BDH	333.17	30.81	4.4	16.26	18.74
iStreet Network Ltd.	ISTRNETWK	345.25	69.03	7.31	0	0
Medicamen Biotech Ltd.	MEDICAM	328.49	33.59	1.2	9.89	12.99
Astal Laboratories Ltd.	ASTALLTD	350.74	43.22	1.05	0.12	0.16
Trident Lifeline Ltd.	TLL	313.3	16.43	3.37	0	33.7

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 25.72x compared with the displayed peer median of 33.59x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.31% compares with a peer median of 0.12% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 12.99%, providing a capital-efficiency comparison. Medico Remedies Ltd. (MEDICO) has a market capitalisation of Rs 337.33 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Medico Remedies Ltd. is compared with peers such as BDH Industries Ltd., iStreet Network Ltd., Medicamen Biotech Ltd., Astal Laboratories Ltd., and Trident Lifeline Ltd. In terms of market capitalisation, Medico Remedies Ltd. stands at Rs 337.33 crore, comparable to its peers. Its P/E ratio of 25.72 is lower than iStreet Network Ltd.'s 69.03 but higher than Trident Lifeline Ltd.'s 16.43.

The company's P/B ratio of 4.47 is higher than Medicamen Biotech Ltd.'s 1.2, indicating a premium valuation. In terms of profitability, Medico Remedies Ltd.'s ROE of 8.31% is lower than BDH Industries Ltd.'s 16.26% but higher than Astal Laboratories Ltd.'s 0.12%. The ROCE of 10.13% is below Trident Lifeline Ltd.'s 33.7%, highlighting differences in capital efficiency among peers.

Why Investors Are Watching Medico Remedies Ltd.

Medico Remedies Ltd. has captured investor attention with its significant price rise today. The stock's performance, technical position, and fundamental context are key factors driving interest.

• Price Action: Surged 8.73% to Rs 44.2, surpassing the micro-cap threshold.
• Technical Position: RSI at 39.72 indicates weak momentum.
• Fundamental Context: P/E of 25.72, above industry median.
• Sector Positioning: Operates in the competitive Pharmaceuticals & Drugs industry.

Investors should monitor Medico Remedies Ltd. for further developments in its market performance and sector dynamics, as these factors could influence future stock movements.

About Medico Remedies Ltd.

Medico Remedies Ltd. operates within the Pharmaceuticals & Drugs industry, focusing on the development and manufacturing of pharmaceutical products. The company is part of the Healthcare sector, which is known for its critical role in providing essential medicines and healthcare solutions. Medico Remedies Ltd. serves a diverse market, offering a range of products that cater to various medical needs.

The company's business model involves the production and distribution of pharmaceutical formulations, which are essential for treating a wide array of health conditions. As a player in the Pharmaceuticals & Drugs industry, Medico Remedies Ltd. is positioned to leverage its expertise in drug development and manufacturing to meet the growing demand for healthcare products. Its market presence and product offerings contribute to its standing within the industry.

Track Medico Remedies Ltd. Share Price on Univest

Use Medico Remedies Ltd. (MEDICO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and market enthusiasts can track Medico Remedies Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share prices, technical indicators, fundamental ratios, and shareholding patterns. Users can also access information on 52-week levels and market insights, making it a valuable resource for informed investment decisions.

Frequently Asked Questions

What is the current share price of Medico Remedies Ltd.?

Ans. The current share price of Medico Remedies Ltd. is Rs 44.2, reflecting an 8.73% increase from the previous close of Rs 40.65. The stock moved 8.73% during the session. The intraday range extended from Rs 40.2 to Rs 44.31.

How much did Medico Remedies Ltd. share price rise today?

Ans. Medico Remedies Ltd. share price rose by 8.73% today, reaching Rs 44.2, making it one of the top gainers in the micro-cap category. The stock moved 8.73% during the session.

What is the market capitalisation of Medico Remedies Ltd.?

Ans. The market capitalisation of Medico Remedies Ltd. is Rs 337.33 crore, positioning it within the micro-cap category. The company operates in the Healthcare sector. Its P/E ratio is 25.72x. ROE is 8.31% and ROCE is 10.13%.

What is the P/E ratio of Medico Remedies Ltd.?

Ans. Medico Remedies Ltd. has a P/E ratio of 25.72, which is above the industry median of 18.4, indicating a higher valuation. The company trades at a P/E ratio of 25.72x.

How does Medico Remedies Ltd.'s ROE compare to the industry?

Ans. Medico Remedies Ltd.'s ROE is 8.31%, slightly below the industry median of 9.93%, suggesting room for improvement in profitability. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 9.93%.

What sector does Medico Remedies Ltd. operate in?

Ans. Medico Remedies Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs. 137 comparable companies were included in the benchmark.

How does Medico Remedies Ltd.'s P/B ratio compare to peers?

Ans. Medico Remedies Ltd.'s P/B ratio of 4.47 is higher than the industry median of 1.84, indicating a premium valuation. The company trades at a P/E ratio of 25.72x. Its P/B ratio is 4.47x.